Enter your terms above and click the 'Search' button.

Showing articles 0 to 4 of 4 Filter Applied: cost (Click to remove) Cost-Effectiveness and Value-Based Pricing of Aducanumab for Patients with Early Alzheimer Disease Neurol 98:e968-e977, Whittington, M.D.,et al, 2022 Controversy and Progress in Alzheimers Disease - FDA Approval of Aducanumab NEJM 385:doi:10.1056/NEJMp2111320, Rabinovici, G.D., 2021 Second Drug Okayed for Rare Central Nervous System Disease JAMA 324:224, Jaklevic, M.C., 2020 Acute Viral Encephalitis NEJM 379:357-366, Tyler,K.L., 2018 Showing articles 0 to 4 of 4